(Q54569398)

1 June 2018

title

Methylation status and protein expression of RASSF1A in breast cancer patients. (English)

1 reference

1 June 2018

author name string

Hoda A Hagrass

1

1 reference

1 June 2018

Heba F Pasha

2

1 reference

1 June 2018

Mohamed A Shaheen

3

1 reference

1 June 2018

Eman H Abdel Bary

4

1 reference

1 June 2018

Rasha Kassem

5

1 reference

1 June 2018

publication date

20 November 2013

1 reference

1 June 2018

Molecular Biology Reports

published in

1 reference

1 June 2018

volume

41

1 reference

1 June 2018

issue

1

1 reference

1 June 2018

page(s)

57-65

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1007/s11033-013-2837-3

exact match

0 references

cites work

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Emerging molecular markers of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

The power and the promise of DNA methylation markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Cancer epigenetics comes of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Quantitative assessment of promoter hypermethylation during breast cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

DNA methylation, chromatin inheritance, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Worms gang up on bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Promoter CpG island hypermethylation during breast cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Estrogen receptor/progesterone receptor-negative breast cancers of young African-American women have a higher frequency of methylation of multiple genes than those of Caucasian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Detection of aberrant methylation of four genes in plasma DNA for the detection of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2837-3

Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia.

21 January 2018

1 reference

12 December 2020

Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.

1 reference

12 December 2020

Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers

1 reference

12 December 2020

Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions

1 reference

12 December 2020

High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma

1 reference

12 December 2020

Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR

1 reference

12 December 2020

Silencing of tumor suppressor genes RASSF1A, SLIT2, and WIF1 by promoter hypermethylation in hereditary breast cancer

1 reference

12 December 2020

Hypermethylation in histologically distinct classes of breast cancer

1 reference

12 December 2020

Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer

1 reference

12 December 2020

A gene hypermethylation profile of human cancer

1 reference

12 December 2020

Evaluation of the level of knowledge of Egyptian women of breast cancer and its risk factors. A cross sectional study

1 reference

12 December 2020

Expression and promoter methylation of the RASSF1A gene in sporadic breast cancers in Chinese women.

1 reference

12 December 2020

Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon

1 reference

12 December 2020

Alterations in DNA methylation: a fundamental aspect of neoplasia

1 reference

12 December 2020

DNA methylation in serum of breast cancer patients: an independent prognostic marker

1 reference

12 December 2020

The fundamental role of epigenetic events in cancer

1 reference

12 December 2020

10.1007/S11033-013-2837-3

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018